Steven Reichling - Jan 13, 2023 Form 4 Insider Report for Accelerate Diagnostics, Inc (AXDX)

Role: Chief Financial Officer
Signature: /s/ Steve Reichling
Stock symbol: AXDX
Transactions as of: Jan 13, 2023
Transactions value $: -$3,264
Form type: 4
Date filed: 1/17/2023, 04:18 PM
Previous filing: Aug 22, 2022
Next filing: Feb 15, 2023

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	AXDX	Common Stock	Options Exercise	$0	+9.44K	+13.99%	$0.00	76.9K	Jan 13, 2023	Direct	F1
transaction	AXDX	Common Stock	Sale	-$3.26K	-4.73K	-6.15%	$0.69	72.2K	Jan 13, 2023	Direct	F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	AXDX	Employee Restricted Stock Units	Options Exercise	$0	-9.44K	-100%	$0.00^*	0	Jan 13, 2023	Common Stock	9.44K		Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The Reporting Person was granted restricted stock units ("RSUs"), which represent a contingent right to receive one share of Common Stock for each RSU. On March 13, 2021, the reporting person was granted a total of 113,265 restricted stock units, which vests in equal amounts every month for 12 months.
F2	The sale reported on this Form 4 represents shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting and settlement of RSUs. The sale was to satisfy tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary transaction by the Reporting Person.